Particle.news

Download on the App Store

Rush University Medical Center Halts Hormonal Care for New Minor Patients

Rush halted puberty blockers alongside hormone therapy for new under-18 patients as part of Trump administration funding conditions, sustaining only psychosocial support with external referrals.

Rush University Medical Center on Sept. 13, 2022. (Antonio Perez/Chicago Tribune)
Image
Image
Image

Overview

  • On July 1, Rush University Medical Center paused puberty blockers and hormone therapy for all new patients under 18 across its Chicago network.
  • Existing minor patients may continue treatment only if stopping it would pose potential harm, according to internal policy documents.
  • The health system will maintain mental health, behavioral health and social services for gender care patients of any age and refer minors to outside providers for unavailable treatments.
  • Lurie Children’s Hospital and UI Health have enacted comparable rollbacks of gender-affirming services for minors under the same federal grant threats.
  • Federal enforcement intensified when the Department of Justice subpoenaed over 20 providers of gender-affirming care to minors even as state attorneys general and major medical associations mount legal challenges defending access.